Título:

Uso De Glucocorticoides en La Artritis Reumatoide. ¿Cuándo Y Cómo Deben Usarse Los Esteroides en La Artritis Reumatoide?



Autores: Mónica Fernández CastroJosé Luis Andreu SánchezLucía Silva Fernández
Año: 2007
Número de citaciones: 1

Gente clave para Artritis Reumatoide

Los KOLs mas influyentes del mundo
#1
Paul *****
rheumatoid arthritis ankylosing spondylitis radiographic progression
#2
Maxime * ********
rheumatoid arthritis ankylosing spondylitis desir cohort
#3
Josef ********* ******
rheumatoid arthritis systemic lupus erythematosus radiographic progression
#4
Bernard * *****
rheumatoid arthritis espoir cohort certolizumab pegol
#5
GerdRüdiger * *********
rheumatoid arthritis rheumatic diseases systemic lupus erythematosus
#6
Piet * * * *** ****
rheumatoid arthritis disease activity score monoclonal antibodies

Uso de glucocorticoides en la artritis reumatoide. ¿Cuándo y cómo deben usarse los esteroides en la artritis reumatoide?

Abstract

Glucocorticoids (GC) are a mainstay of the therapy in rheumatoid arthritis (RA). Currently, and despite their extensive use, the discussion about the benefits and adverse effects of low dose GC in the management of RA persists. In recent years, a number of clinical trials have attempted to establish the benefits of long-term GC use as a disease-modifying antirheumatic drug in RA, and to define their side effects. Results of these clinical trials provide solid evidence that low-dose GC can inhibit radiographic damage in early RA, and that side effects of GC, when used in that clinical framework, are limited to hyperglycaemia, cataracts, and transient weight gain.

Inicie sesión para ver todos los conceptos, ¡es gratis!